Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Insignia

Research Leaders

5 sponsors active, led by Canadian Radiostereometric Analysis Network

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Not Yet Recruiting1
Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07048080Not ApplicableNot Yet RecruitingPrimary

Prehabilitation in Older People Undergoing Total Hip Replacement

NCT06696313Not ApplicableActive Not Recruiting

Radiographic Migration Analysis of the Insignia Hip Stem

NCT01894854Not ApplicableCompletedPrimary

RSA Study of Furlong Evolution With and Without Collar

Showing all 3 trials

Research Network

Common Treatments

  • Insignia1
  • Stem Collar1
  • Usual Care1
  • Usual Care Group Deuterated Water1
  • Prehabilitation Progresive Resistance Exercise Training1

Active Sponsors

  • Canadian Radiostereometric Analysis Network1
  • Region Skane1
  • Orthopaedic Innovation Centre1
  • JRI Orthopaedics Ltd1
  • Universidad de La Frontera1

Top Investigators

Related Conditions

  • Migration Of Implant1
  • Osteoarthritis Hip1
  • Hip Implant1

Activity Timeline